Replies to post #186275 on Biotech Values

[DewDiligence]

(PPHM)—You evidently don’t understand how FMI operates. When FMI recommends a clinical trial for an individual patient, the recommendation is based on the patient’s biopsy and the genomic information in FMI’s database—there is no favoritism based on who is or isn’t sponsoring the trial in question.